“Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors”. Journal of Kidney Cancer 12, no. 2 (May 5, 2025): 37–45. Accessed September 25, 2025. https://jkcvhl.com/index.php/jkcvhl/article/view/386.